Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1146320200080010020
Journal of Health Technology Assessment
2020 Volume.8 No. 1 p.20 ~ p.25
A Review of Current Drugs for COVID-19
Park Seon-Young

Suh Hae-Sun
Abstract
In December 2019, a new coronavirus-related pneumonia occurred in Wuhan, Hubei province, China. The virus was named acute acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the World Health Organization named the disease COVID-19. The disease became pandemic, causing numerous patients and deaths in a short time. However, despite this epidemic situation, there are currently no Food and Drug Administration-approved drugs to treat with COVID-19. Therefore, in this review, we will discuss the drugs currently used in the treatment of COVID-19 based on the COVID-19 treatment guidelines issued by the Centers for Disease Control and Prevention.
KEYWORD
Coronavirus disease 2019, COVID-19, SARS-CoV-2, Treatment
FullTexts / Linksout information
Listed journal information